GLP-1/exendin-4 facilitates beta-cell neogenesis in rat and human pancreatic ducts.
Xu
Gang
G
Kaneto
Hideaki
H
Lopez-Avalos
Maria D
MD
Weir
Gordon C
GC
Bonner-Weir
Susan
S
D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy / Q000473:pathology; D000077270:Exenatide; D052216:Glucagon-Like Peptide 1 / Q000494:pharmacology*; D000067757:Glucagon-Like Peptide-1 Receptor; D006801:Humans; D050417:Insulin-Secreting Cells / Q000166:cytology* / Q000187:drug effects; D008297:Male; D010183:Pancreatic Ducts / Q000166:cytology* / Q000187:drug effects; D010455:Peptides / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats; D018027:Receptors, Glucagon / Q000096:biosynthesis; D014688:Venoms / Q000494:pharmacology* / Q000627:therapeutic use
C000593833:GLP1R protein, human; C000593835:Glp1r protein, rat; D000067757:Glucagon-Like Peptide-1 Receptor; D010455:Peptides; D018027:Receptors, Glucagon; D014688:Venoms; D052216:Glucagon-Like Peptide 1; D000077270:Exenatide